• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素对面部表情肌的美容去神经支配:一项剂量反应研究。

Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.

作者信息

Garcia A, Fulton J E

出版信息

Dermatol Surg. 1996 Jan;22(1):39-43. doi: 10.1111/j.1524-4725.1996.tb00569.x.

DOI:10.1111/j.1524-4725.1996.tb00569.x
PMID:8556256
Abstract

BACKGROUND

Botulinum toxin has been used for facial hemispasm, strabismus, and blepharospasm. Recently it has been advocated to treat the frown lines. We have extended this program to treatment of other muscles of facial expression.

METHODS

Botulinum toxin is injected into the muscles of facial expression in two or three sessions to produce a temporary loss of muscle tone. A standard method of cooling, injection, and compression was developed to minimize pain and bruising.

OBJECTIVE

To complete a dose-response study to document the optimum timing and amount of toxin needed for each muscle group.

RESULTS

Two to five Botulinum toxin units per muscle was as adequate as higher doses. Toxin that was reconstituted 30 days earlier produced the same loss of muscle tone as freshly mixed toxin. With two or three injection sessions loss of muscle tone lasted for up to 1 year.

CONCLUSION

Botulinum toxin is highly effective as an adjuvant therapy for facial rejuvenation. This minor surgical procedure can temporarily reduce the lines on the upper face and produce a pleasing effect. With proper dosing and dilution this rejuvenation program becomes cost effective.

摘要

背景

肉毒杆菌毒素已被用于治疗面部痉挛、斜视和眼睑痉挛。最近有人主张用其治疗皱眉纹。我们已将该方案扩展至治疗其他面部表情肌。

方法

分两到三次将肉毒杆菌毒素注射到面部表情肌中,以使肌肉张力暂时丧失。开发了一种标准的冷却、注射和按压方法,以尽量减少疼痛和瘀伤。

目的

完成一项剂量反应研究,以记录每个肌肉群所需毒素的最佳时间和剂量。

结果

每块肌肉注射2至5个肉毒杆菌毒素单位与更高剂量同样有效。提前30天复溶的毒素产生的肌肉张力丧失与新鲜混合的毒素相同。经过两到三次注射,肌肉张力丧失可持续长达1年。

结论

肉毒杆菌毒素作为面部年轻化的辅助治疗非常有效。这种小手术可暂时减少上脸皱纹并产生令人满意的效果。通过适当的给药和稀释,这种年轻化方案具有成本效益。

相似文献

1
Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.肉毒杆菌毒素对面部表情肌的美容去神经支配:一项剂量反应研究。
Dermatol Surg. 1996 Jan;22(1):39-43. doi: 10.1111/j.1524-4725.1996.tb00569.x.
2
The use of botulinum A toxin to ameliorate facial kinetic frown lines.使用A型肉毒杆菌毒素改善面部动态皱纹。
Ophthalmology. 1996 Apr;103(4):618-22. doi: 10.1016/s0161-6420(96)30644-1.
3
Botulinum toxin. The Newport Beach experience.肉毒杆菌毒素。纽波特海滩的经验。
Dermatol Surg. 1998 Nov;24(11):1219-24.
4
Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents.用于面部年轻化的注射剂:肉毒杆菌毒素和真皮填充剂。
Int Ophthalmol Clin. 2004 Winter;44(1):189-212. doi: 10.1097/00004397-200404410-00018.
5
Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear.皱眉肌的药物去神经支配增强了幸福的基线表达,并降低了愤怒、悲伤和恐惧的基线表达。
J Am Acad Dermatol. 2003 Aug;49(2):213-6. doi: 10.1067/s0190-9622(03)00909-5.
6
The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.肉毒杆菌毒素治疗面部功能亢进性皱纹。对162例患者的210个注射部位进行的一项合作研究。
Arch Otolaryngol Head Neck Surg. 1997 Apr;123(4):389-92. doi: 10.1001/archoto.123.4.389.
7
Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.A型肉毒杆菌毒素用于面部年轻化。美国和英国的观点。
Dermatol Surg. 1998 Nov;24(11):1216-8. doi: 10.1111/j.1524-4725.1998.tb04100.x.
8
Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.了解肉毒杆菌毒素。皱眉肌、额部及眼周区域的手术解剖学。
Dermatol Surg. 1998 Nov;24(11):1172-4.
9
Botulinum A toxin for glabellar wrinkles. Dose and response.用于眉间纹的A型肉毒毒素。剂量与反应。
Dermatol Surg. 1998 Nov;24(11):1181-3. doi: 10.1111/j.1524-4725.1998.tb04095.x.
10
Oculoplastic experience with the cosmetic use of botulinum A exotoxin.眼部整形中肉毒杆菌A外毒素美容用途的经验
Dermatol Surg. 1998 Nov;24(11):1208-12. doi: 10.1111/j.1524-4725.1998.tb04099.x.

引用本文的文献

1
Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact.肉毒毒素(注射用A型肉毒毒素)治疗眉间纹:发展、见解和影响。
Medicine (Baltimore). 2023 Jul 1;102(S1):e32375. doi: 10.1097/MD.0000000000032375.
2
A Comparative Analysis of Online Reporting of Possible Complications for Minimally Invasive Cosmetic Procedures.微创美容手术可能并发症的在线报告比较分析
Eplasty. 2023 Mar 10;23:e17. eCollection 2023.
3
Immunogenicity of botulinum toxin.肉毒杆菌毒素的免疫原性。
Arch Plast Surg. 2022 Jan;49(1):12-18. doi: 10.5999/aps.2021.00766. Epub 2022 Jan 15.
4
Effective Locations for Injecting Botulinum Toxin into the Mentalis Muscle; Cadaveric and Ultrasonographic Study.将肉毒毒素注入提肌的有效部位;尸体和超声研究。
Toxins (Basel). 2021 Jan 27;13(2):96. doi: 10.3390/toxins13020096.
5
Comparison study of the response with botulinum toxin muscle injection in the ICR mice from three different sources.三种不同来源的ICR小鼠肉毒杆菌毒素肌肉注射反应的比较研究。
Lab Anim Res. 2019 Jul 26;35:11. doi: 10.1186/s42826-019-0010-4. eCollection 2019.
6
Clinical uses of botulinum toxin A in smile aesthetic modification.肉毒杆菌毒素A在微笑美学修饰中的临床应用。
Br Dent J. 2018 Sep 28;225(6):502-506. doi: 10.1038/sj.bdj.2018.755.
7
Botulinum neurotoxin formulations: overcoming the confusion.肉毒杆菌神经毒素制剂:消除混淆
Clin Cosmet Investig Dermatol. 2018 May 30;11:273-287. doi: 10.2147/CCID.S156851. eCollection 2018.
8
Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.用于美学领域的阿柏西普肉毒素A的关键参数:起效时间和持续时间。
Aesthet Surg J. 2017 May 1;37(suppl_1):S20-S31. doi: 10.1093/asj/sjw282.
9
Effects of a botulinum toxin type A injection on the masseter muscle: An animal model study.A型肉毒杆菌毒素注射对咬肌的影响:一项动物模型研究。
Maxillofac Plast Reconstr Surg. 2015 Feb 24;37(1):10. doi: 10.1186/s40902-015-0010-8. eCollection 2015 Dec.
10
Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis.冰箱储存时间对肉毒杆菌毒素治疗人伸趾短肌瘫痪效果的影响。
J Clin Neurol. 2013 Jul;9(3):157-64. doi: 10.3988/jcn.2013.9.3.157. Epub 2013 Jul 1.